A Humanized Mouse Identifies the Bone Marrow as a Niche with Low Therapeutic IgG Activity-Reference-Cited by-同舟云学术

A Humanized Mouse Identifies the Bone Marrow as a Niche with Low Therapeutic IgG Activity

Published:2014-04 Issue:1 Volume:7 Page:236-248
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Lux Anja,Seeling Michaela,Baerenwaldt Anne,Lehmann Birgit,Schwab Inessa,Repp Roland,Meidenbauer Norbert,Mackensen Andreas,Hartmann Arndt,Heidkamp Gordon,Dudziak Diana,Nimmerjahn Falk

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference60 articles.

1. Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo;Baerenwaldt;Proc. Natl. Acad. Sci. USA,2011

2. Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a- and IgG2b-induced autoimmune hemolytic anemia in mice;Baudino;J. Immunol.,2008

3. Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation;Beers;Blood,2008

4. Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection;Beers;Blood,2010

5. Low level of FcγRIII expression on murine natural killer cells;Biburger;Immunol. Lett.,2012

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement;Immunological Reviews;2024-09-13

2. Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy;Antibodies;2024-04-18

3. A human immune system (HIS) mouse model that dissociates roles for mouse and human FcR⁺ cells during antibody‐mediated immune responses;European Journal of Immunology;2023-08-31

4. Phenotyping of Macrophages in Human Immune System Mice;Methods in Molecular Biology;2023-08-29

5. Fcγ-receptor-independent controlled activation of CD40 canonical signaling by novel therapeutic antibodies for cancer therapy;2023-07-27